Yahoo Web Search

Search results

    • Q1 2024 Viking Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 7 hours ago

      In addition to the subcutaneous formulation, the company is also developing a novel oral tablet formulation of VK. two 75. We believe a tablet formulation could represent.